Before I get burnt for downramping, the numbers I refer to above for first 6 months of FY16 dont include the 15million up front payment from Amgen as I am looking at the numbers from usual business operations. Hence my later point of some further deals with up fronts still seem to be needed. They have bene too infrequent in the past, not sure they will be any more forthcoming in the future?!?